Genetic factors and comorbid pathologies interact to drive regional mitophagy alterations in Lewy body dementia
Open Access
- 1 December 2025
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 150 (1) , 59
Abstract
The kinase–ligase pair PINK1–PRKN initiates mitophagy by recognizing and selectively tagging worn-out and dysfunctional mitochondria with phosphorylated ubiquitin (pS65-Ub) to facilitate their elimination via autophagy. In human autopsy brains, the number of pS65-Ub positive cells increases with age but is also associated with Lewy body (LB), neurofibrillary tangles (NFT), and senile plaque (SP) burden. Through a recent genome-wide association study, we identified two genetic modifiers of pS65-Ub levels, APOE4 and ZMIZ1 rs6480922. While LB, NFT, and SP pathologies often coexist in Lewy body dementia (LBD), it is unclear how genetic factors and comorbid neuropathologies interact to impact mitophagy in vulnerable brain regions. We therefore measured levels of the age and disease marker pS65-Ub in the hippocampus and amygdala of 371 LBD cases. Significant and independent associations with pS65-Ub levels were observed for each of the three pathologies LB, NFT, and SP in both regions, and the presence of APOE4 significantly strengthened the association between NFT and pS65-Ub in the hippocampus. While no interaction between LB and SP pathologies was observed regarding association with pS65-Ub, a significant interaction between LB and NFT pathologies on pS65-Ub accumulation was found in the amygdala, which was primarily observed in carriers of the minor allele of ZMIZ1 rs6480922. In summary, our study revealed complex interactions between LB pathology, NFT pathology, and genetic mitophagy modifiers in LBD brains, highlighting potential convergent molecular mechanisms underlying α-synuclein- and tau-associated mitophagy alterations.Keywords
Funding Information
- Mayo Clinic Alzheimer Disease Research Center
- National Institute of Neurological Disorders and Stroke (U54NS110435)
This publication has 76 references indexed in Scilit:
- Zmiz1-Mediated SUMOylation of NLRP3 Inflammasome Regulates Satellite Glial Cell Activation and Neuronal Autophagy in Trigeminal NeuralgiaInflammation, 2025
- Unravelling the Proteinopathic Engagement of α-Synuclein, Tau, and Amyloid Beta in Parkinson’s Disease: Mitochondrial Collapse as a Pivotal Driver of NeurodegenerationNeurochemical Research, 2025
- Genome‐wide association analysis identifies APOE as a mitophagy modifier in Lewy body diseaseAlzheimer's & Dementia, 2025
- ZMIZ proteins: partners in transcriptional regulation and risk factors for human diseaseJournal of Molecular Medicine, 2022
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesisAlzheimer's & Dementia, 2022
- Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathologyAlzheimer's & Dementia, 2020
- Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathologyActa Neuropathologica, 2019
- A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy BodiesJAMA Neurology, 2013
- APOE ϵ4 Increases Risk for Dementia in Pure SynucleinopathiesJAMA Neurology, 2013
- Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disordersActa Neuropathologica, 1996